ASTS Yahoo Finance options chain reflects increased call buying at $5 strike for August expiry, signaling speculative bets on upward movement linked to Q3 operational updates. However, the deal has been met with resistance from some of Core Scientific’s top shareholders. According to sources familiar with the matter, a number of these investors are preparing to vote against the merger unless the terms are adjusted. The core issue lies in the fixed ratio of 0.1235 newly issued CoreWeave ( CRWV ) shares offered to Core Scientific ( CORZ ) shareholders. This arrangement does not offer any protection if CoreWeave’s stock price declines, which it has done significantly since the merger was first announced. For the annual period, the Zacks Consensus Estimates anticipate earnings of -$0.98 per share and a revenue of $53.9 million, signifying shifts of -48.48% and +1119.99%, respectively, from the last year.